[go: up one dir, main page]

AU2002337803A1 - Sustained release pharmaceutical compositions - Google Patents

Sustained release pharmaceutical compositions

Info

Publication number
AU2002337803A1
AU2002337803A1 AU2002337803A AU2002337803A AU2002337803A1 AU 2002337803 A1 AU2002337803 A1 AU 2002337803A1 AU 2002337803 A AU2002337803 A AU 2002337803A AU 2002337803 A AU2002337803 A AU 2002337803A AU 2002337803 A1 AU2002337803 A1 AU 2002337803A1
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
sustained release
release pharmaceutical
sustained
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002337803A
Inventor
Michael Keith Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2002337803A1 publication Critical patent/AU2002337803A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002337803A 2001-10-03 2002-10-03 Sustained release pharmaceutical compositions Abandoned AU2002337803A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32740801P 2001-10-03 2001-10-03
US60/327,408 2001-10-03
PCT/US2002/031422 WO2003028653A2 (en) 2001-10-03 2002-10-03 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
AU2002337803A1 true AU2002337803A1 (en) 2003-04-14

Family

ID=23276439

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002337803A Abandoned AU2002337803A1 (en) 2001-10-03 2002-10-03 Sustained release pharmaceutical compositions

Country Status (2)

Country Link
AU (1) AU2002337803A1 (en)
WO (1) WO2003028653A2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007328207A1 (en) 2006-12-05 2008-06-12 Landec Corporation Drug delivery
WO2010033200A2 (en) 2008-09-19 2010-03-25 President And Fellows Of Harvard College Creation of libraries of droplets and related species
CN102770151B (en) 2009-08-03 2018-07-31 因卡伯实验室有限责任公司 Swallowable capsule and method for stimulating incretin production in the gut
US8562589B2 (en) 2009-12-24 2013-10-22 Rani Therapeutics, Llc Swallowable drug delivery device and method of delivery
US8980822B2 (en) 2010-12-23 2015-03-17 Rani Therapeutics, Llc Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9284367B2 (en) * 2010-12-23 2016-03-15 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9861683B2 (en) 2010-12-23 2018-01-09 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9283179B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9415004B2 (en) 2010-12-23 2016-08-16 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9629799B2 (en) 2010-12-23 2017-04-25 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8809269B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8734429B2 (en) 2010-12-23 2014-05-27 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US8809271B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US10639272B2 (en) 2010-12-23 2020-05-05 Rani Therapeutics, Llc Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
US9402807B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402806B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9149617B2 (en) 2010-12-23 2015-10-06 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US8846040B2 (en) 2010-12-23 2014-09-30 Rani Therapeutics, Llc Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8969293B2 (en) 2010-12-23 2015-03-03 Rani Therapeutics, Llc Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8764733B2 (en) 2010-12-23 2014-07-01 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9259386B2 (en) 2010-12-23 2016-02-16 Rani Therapeutics, Llc Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
EP3065712A4 (en) * 2013-11-08 2017-06-21 President and Fellows of Harvard College Microparticles, methods for their preparation and use
CN104434855B (en) * 2014-12-10 2017-02-01 哈药集团技术中心 Memantine hydrochloride tablet and preparation method thereof
CN104398485B (en) * 2014-12-10 2017-05-10 哈药集团技术中心 Olmesartan medoxomil tablet and preparation method thereof
CN104434854B (en) * 2014-12-10 2017-03-29 哈药集团技术中心 A kind of minodronic acid tablet recipe and its preparation technology
JP2018537414A (en) 2015-10-13 2018-12-20 プレジデント アンド フェローズ オブ ハーバード カレッジ System and method for making and using gel microspheres

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568559A (en) * 1984-02-06 1986-02-04 Biotek, Inc. Composite core coated microparticles and process of preparing same
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
KR100321649B1 (en) * 1993-03-17 2002-07-22 미네소타 마이닝 앤드 매뉴팩춰링 캄파니 Aerosols containing dispersion aids derived from esters, amides or mercaptoesters
US6136294C1 (en) * 1998-09-22 2002-09-24 Aeropharm Technology Inc Amino acid stabilized medical aerosol formulation

Also Published As

Publication number Publication date
WO2003028653A3 (en) 2004-03-11
WO2003028653A2 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
AU2002258563A1 (en) Pharmaceutical formulations for sustained release
AU2002337803A1 (en) Sustained release pharmaceutical compositions
AU781269C (en) Pharmaceutical compositions
AU2002313236A1 (en) Medicinal compositions
AUPR602501A0 (en) Sustained release pharmaceutical composition
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
AU2002302147A1 (en) Pharmaceutical composition
AU2003260803A1 (en) Sustained release pharmaceutical composition
AU2002258221A1 (en) Medicinal composition
AU2001264264A1 (en) Sustained release compositions
AU2001248772A1 (en) Sustained release drug compositions
AU2001273919A1 (en) Pharmaceutical compositions
AU2003216503A1 (en) Stable pharmaceutical compositions
AU2002354460A1 (en) Medicinal composition
AUPR529701A0 (en) Pharmaceutical composition
AU2002346223A1 (en) Medicinal compositions
AU2001285737A1 (en) Pharmaceutical compositions
AU2002326822A1 (en) Pro-micelle pharmaceutical compositions
AU2002100921A4 (en) Pharmaceutical composition
AUPS008402A0 (en) Sustained release pharmaceutical composition
AU2002306341A1 (en) Medicinal compositions
AU2002327341A1 (en) Thrombomodulin-containing medicinal compositions
AU2002256916A1 (en) Medicinal compositions
HK1062631A (en) Pharmaceutical composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase